The Food and Drug Administration’s concerns about continued marketing of noncompliant topical analgesics get an indelible stamp of urgency as more US adults are having tattoos applied, and a higher number still will get one or more.
The FDA on 26 March announced warning letters to six businesses found selling directly to consumers topical formulations containing lidocaine...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?